BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Verge Genomics

Verge Genomics logo

United States of America based
$36.120 M

We are pioneering a better drug discovery process using systems biology to improve the lives of people with neurodegenerative disorders. YC S15.

Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, we share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.


AI Companies (Drug Discovery)   Pharmaceutical and Drug Discovery  

Posts Mentioning This Company

Biopharma Insights

R&D Platform

Map hundreds of genes that cause a disease, then find drugs that target all at once. Allows researchers to: Find cures for complex diseases—especialy brain diseases—that involve a network of genes.


No pipelines published yet




No services posted yet